These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17933809)

  • 1. ISOPP standards of practice. Safe handling of cytotoxics.
    International Society of Oncology Pharmacy Practicioners Standards Committee
    J Oncol Pharm Pract; 2007; 13 Suppl():1-81. PubMed ID: 17933809
    [No Abstract]   [Full Text] [Related]  

  • 2. An evaluation of chemotherapy drug preparation process in hospitals in Turkey - A pilot study.
    Bayraktar-Ekincioglu A; Korubük G; Demirkan K
    J Oncol Pharm Pract; 2018 Dec; 24(8):563-573. PubMed ID: 28728495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safe handling of cytotoxic agents: a team approach.
    Willemsen-McBride T; Gehan K
    AORN J; 2009 Nov; 90(5):731-2, 735-40. PubMed ID: 19895929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What are your concerns regarding safe handling of chemotherapy?
    Eisenberg S
    ONS Connect; 2008 Aug; 23(8):15. PubMed ID: 18767568
    [No Abstract]   [Full Text] [Related]  

  • 5. Why do nurses resist safe-handling behaviors?
    Wujcik DM
    ONS Connect; 2008 Aug; 23(8):7. PubMed ID: 18767566
    [No Abstract]   [Full Text] [Related]  

  • 6. Survey of guidelines and current practices for safe handling of antineoplastic and other hazardous drugs used in 24 countries.
    Mathias PI; MacKenzie BA; Toennis CA; Connor TH
    J Oncol Pharm Pract; 2019 Jan; 25(1):148-162. PubMed ID: 28841099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safe handling of chemotherapy.
    Saca-Hazboun H
    ONS Connect; 2008 Aug; 23(8):10-4. PubMed ID: 18767567
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of a flowchart for risk assessment and allocation of preparation of monoclonal antibodies.
    Bauters T; Vandenbroucke J
    J Oncol Pharm Pract; 2019 Jan; 25(1):187-191. PubMed ID: 29199505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ONS advocates for safe handling of hazardous drugs.
    Rieger PT
    ONS Connect; 2008 Aug; 23(8):29. PubMed ID: 18767574
    [No Abstract]   [Full Text] [Related]  

  • 10. Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations.
    Ashe K; Baskett D
    Int J Pharm Compd; 2018; 22(5):387-398. PubMed ID: 30384337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ISOPP Standards for the Safe Handling of Cytotoxics.
    J Oncol Pharm Pract; 2022 Apr; 28(3_suppl):S1-S126. PubMed ID: 36579973
    [No Abstract]   [Full Text] [Related]  

  • 12. Antineoplastic agent workplace contamination study: the Alberta Cancer Board Pharmacy perspective.
    Schulz H; Bigelow S; Dobish R; Chambers CR
    J Oncol Pharm Pract; 2005 Sep; 11(3):101-9. PubMed ID: 16390598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A report on the National Commission on Cytotoxic Exposure.
    Gallelli JF
    J Pharm Technol; 1992; 8(2):55-64. PubMed ID: 10118896
    [No Abstract]   [Full Text] [Related]  

  • 14. Application and assessment of a regular environmental monitoring of the antineoplastic drug contamination level in pharmacies - the MEWIP project.
    Kiffmeyer TK; Tuerk J; Hahn M; Stuetzer H; Hadtstein C; Heinemann A; Eickmann U
    Ann Occup Hyg; 2013 May; 57(4):444-55. PubMed ID: 23125441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Society of Hospital Pharmacists of Australia: are you at risk?
    Aust Hosp; 1981 Jul; (54):4-5. PubMed ID: 10254354
    [No Abstract]   [Full Text] [Related]  

  • 16. Investigation on residual-related error and the effect of solution properties using protective devices for the reconstitution of cytotoxic agents in actual situations.
    Hama K; Kitada N; Fukushima K; Hashida T; Kataoka K
    J Oncol Pharm Pract; 2011 Mar; 17(1):55-60. PubMed ID: 20605849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Double, double, toil and trouble': for modern practitioners of compounding, standards and training are critical [interview by Lisa Santandrea].
    Allen LV
    Am J Nurs; 2003 May; 103(5):83. PubMed ID: 12762333
    [No Abstract]   [Full Text] [Related]  

  • 18. Occupational exposure to conventional antineoplastic drugs: can it be further limited?
    Simon N; Odou P; Décaudin B; Bonnabry P; Fleury Souverain S
    Eur J Hosp Pharm; 2020 Sep; 27(5):251-252. PubMed ID: 32839255
    [No Abstract]   [Full Text] [Related]  

  • 19. Hazardous Drug Residues in the Home Setting: Worker Safety Concerns.
    Huff C
    J Infus Nurs; 2020; 43(1):15-18. PubMed ID: 31876769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compounding pharmacies: who is in charge?
    Pergolizzi JV; Labhsetwar S; LeQuang JA
    Pain Pract; 2013 Mar; 13(3):253-7. PubMed ID: 23350709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.